Literature DB >> 22811853

Colorectal cancer screening using protected microRNAs.

Nathan R Wall1.   

Abstract

Entities:  

Year:  2011        PMID: 22811853      PMCID: PMC3397620          DOI: 10.3978/j.issn.2078-6891.2011.040

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


× No keyword cloud information.
  15 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 2.  Exosomes: from biogenesis and secretion to biological function.

Authors:  Sascha Keller; Michael P Sanderson; Alexander Stoeck; Peter Altevogt
Journal:  Immunol Lett       Date:  2006-10-17       Impact factor: 3.685

3.  Fecal MicroRNAs as novel biomarkers for colon cancer screening.

Authors:  Alexander Link; Francesc Balaguer; Yan Shen; Takeshi Nagasaka; Juan José Lozano; C Richard Boland; Ajay Goel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-15       Impact factor: 4.254

4.  Functional delivery of viral miRNAs via exosomes.

Authors:  D Michiel Pegtel; Katherine Cosmopoulos; David A Thorley-Lawson; Monique A J van Eijndhoven; Erik S Hopmans; Jelle L Lindenberg; Tanja D de Gruijl; Thomas Würdinger; Jaap M Middeldorp
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-18       Impact factor: 11.205

5.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 6.  Microvesicles: messengers and mediators of tumor progression.

Authors:  Khalid Al-Nedawi; Brian Meehan; Janusz Rak
Journal:  Cell Cycle       Date:  2009-07-11       Impact factor: 4.534

7.  International trends in colorectal cancer incidence rates.

Authors:  Melissa M Center; Ahmedin Jemal; Elizabeth Ward
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06       Impact factor: 4.254

Review 8.  Tumour-released exosomes and their implications in cancer immunity.

Authors:  M Iero; R Valenti; V Huber; P Filipazzi; G Parmiani; S Fais; L Rivoltini
Journal:  Cell Death Differ       Date:  2007-10-12       Impact factor: 15.828

Review 9.  Clinical, biological, and molecular aspects of metastasis in colorectal cancer.

Authors:  Ulrike Stein; Peter M Schlag
Journal:  Recent Results Cancer Res       Date:  2007

10.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.

Authors:  Johan Skog; Tom Würdinger; Sjoerd van Rijn; Dimphna H Meijer; Laura Gainche; Miguel Sena-Esteves; William T Curry; Bob S Carter; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Cell Biol       Date:  2008-11-16       Impact factor: 28.824

View more
  5 in total

1.  Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.

Authors:  Hailing Liu; Yan Wang; Xin Li; Yan-jun Zhang; Jie Li; Yi-qiong Zheng; Mei Liu; Xin Song; Xi-ru Li
Journal:  Tumour Biol       Date:  2013-02-22

2.  The expression and function of microRNA-203 in lung cancer.

Authors:  Jianhua Jin; Jianzhong Deng; Fang Wang; Xiyi Xia; Tiefeng Qiu; Wenbin Lu; Xianwen Li; Hua Zhang; Xiaoyan Gu; Yungang Liu; Weiguo Cao; Wenlong Shao
Journal:  Tumour Biol       Date:  2012-10-17

3.  MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer.

Authors:  Xingzeng Zhang; Genshun Ma; Jianchao Liu; Yajun Zhang
Journal:  Oncol Lett       Date:  2017-08-21       Impact factor: 2.967

4.  Personalized medicine in screening for malignant disease: a review of methods and applications.

Authors:  F Schmalfuss; P L Kolominsky-Rabas
Journal:  Biomark Insights       Date:  2013-02-18

5.  Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.

Authors:  Binh Phan; Shahana Majid; Sarah Ursu; David de Semir; Mehdi Nosrati; Vladimir Bezrookove; Mohammed Kashani-Sabet; Altaf A Dar
Journal:  Oncotarget       Date:  2016-04-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.